Osothasopa Reports 14% Profit Growth, Declares 0.45 Baht Dividend

Osothasopa Public Company Limited (OSP) reported second-quarter 2025 net profit attributable to the company of 1.1 billion baht, up 8.9% from the same period last year despite facing external challenges. Gross margin reached a historic high of 42.8%, driven by improved production efficiency, efficient cost management and supply chain operations, and strong growth in domestic core business. First-half net profit from normal operations reached 2.257 billion baht, up 14% year-on-year, reflecting strong and sustained profit-generating capability. The company declared an interim dividend of 0.45 baht per share.

Mukda Pairatwetwet, Chief Executive Officer of Osothasopa Public Company Limited, said first-half results reflect the strength of the business and continuously improving profit-generating capability. On an adjusted basis, revenue grew 1.7%, while net profit attributable to the company and ordinary profit grew 20.2% and 42.6% respectively, driven by disciplined cost management, enhanced operational efficiency, and product portfolio management aligned with market opportunities.

"For 2025, the company targets low-to-mid-single-digit revenue growth on an adjusted basis, outpacing Thailand's economic expansion rate. We will drive growth through core brands, innovation, and domestic and international market expansion, while continuously improving operational efficiency to create sustainable long-term growth and shareholder returns," she said.

Key second-quarter 2025 results include: net profit attributable to the company of 1.1 billion baht, up 8.9% despite temporary production constraints in Myanmar; gross margin at historic 42.8% from improved production efficiency following factory consolidation, efficient domestic and international supply chain management, and disciplined cost and promotional activity management; domestic beverage sales up 6.0%, driven by comprehensive brand portfolio management including mainstream, premium, and functional drinks, with M-150, Lipovitan-D, C-Vitt, and Peptein as key drivers; personal care up 8.3% from strength of Babi Mild and expansion of Ultra Mild by Babi Mild, broadening consumer base and future growth opportunities; international business excluding Myanmar up 19.5%, though Myanmar operations still face raw material import license constraints, while other overseas markets continued strong growth, reflecting potential for expansion in high-growth markets; disciplined expense management with SG&A ratio at 22.5% of sales, reflecting ROI-driven marketing and promotional activity management and operational improvements; and interim dividend of 0.45 baht per share, with ex-dividend date set for August 27, 2025, and payment date September 10, 2025, reflecting strong financial position and commitment to sustained shareholder returns.